FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frits-Axel Wiesel

Research Profile

Disorders

Procedures

Tomography, Emission-Computed

Chemicals & Drugs

Co-author Network

Publications

TOP 3
B M Nilsson; RM Olsson; A Oman; Frits-Axel Wiesel; L Ekselius; Anders Forslund
Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls.
M L Persson; J Johansson; R Vumma; J Raita; Lars Bjerkenstedt; Frits-Axel Wiesel; Nikolaos Venizelos
Aberrant amino acid transport in fibroblasts from patients with bipolar disorder.
Erik Wennström; Lars Berglund; Johan Lindbäck; Frits-Axel Wiesel
Deconstructing the 'black box' of the Camberwell assessment of need score in mental health services evaluation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frits-Axel Wiesel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: B M Nilsson; RM Olsson; A Oman; Frits-Axel Wiesel; L Ekselius; Anders Forslund
Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(3):206-12.
2009: M L Persson; J Johansson; R Vumma; J Raita; Lars Bjerkenstedt; Frits-Axel Wiesel; Nikolaos Venizelos
Aberrant amino acid transport in fibroblasts from patients with bipolar disorder.
Neuroscience letters 2009;457(1):49-52.
2008: Erik Wennström; Lars Berglund; Johan Lindbäck; Frits-Axel Wiesel
Deconstructing the 'black box' of the Camberwell assessment of need score in mental health services evaluation.
Social psychiatry and psychiatric epidemiology 2008;43(9):714-9.
2008: Ravi Vumma; Frits-Axel Wiesel; Lena Flyckt; Lars Bjerkenstedt; Nikolaos Venizelos
Functional characterization of tyrosine transport in fibroblast cells from healthy controls.
Neuroscience letters 2008;434(1):56-60.
2007: Frits-Axel Wiesel
[Schizophrenia is a systemic disease. Genetic mechanisms and environmental factors interact in the disease development].
Läkartidningen 2007;104(30-31):2146-7.
2007: Elisabeth Fernell; Aristea Karagiannakis; Gunnar Edman; Lars Bjerkenstedt; Frits-Axel Wiesel; Nikolaos Venizelos
Aberrant amino acid transport in fibroblasts from children with autism.
Neuroscience letters 2007;418(1):82-6.
2006: Erik Wennström; Frits-Axel Wiesel
The Camberwell assessment of need as an outcome measure in routine mental health care.
Social psychiatry and psychiatric epidemiology 2006;41(9):728-33.
2006: B M Nilsson; Anders Forslund; RM Olsson; Leif Hambraeus; Frits-Axel Wiesel
Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls.
Acta psychiatrica Scandinavica 2006;114(1):27-35.
2006: B M Nilsson; C M Hultman; Frits-Axel Wiesel
Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
Prostaglandins, leukotrienes, and essential fatty acids 2006;74(5):339-46.
2006: Lars Bjerkenstedt; Lars Farde; Lars Terenius; Gunnar Edman; Nikolaos Venizelos; Frits-Axel Wiesel
Support for limited brain availability of tyrosine in patients with schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(2):247-55.
2006: Emma Olsson; Frits-Axel Wiesel; Lars Bjerkenstedt; Nikolaos Venizelos
Tyrosine transport in fibroblasts from healthy volunteers and patients with schizophrenia.
Neuroscience letters 2006;393(2-3):211-5.
2005: Frits-Axel Wiesel; Gunnar Edman; Lena Flyckt; Asa Eriksson; Håkan Nyman; Nikolaos Venizelos; Lars Bjerkenstedt
Kinetics of tyrosine transport and cognitive functioning in schizophrenia.
Schizophrenia research 2005;74(1):81-9.
2005: Lennart Jansson; Karin Sonnander; Frits-Axel Wiesel
Needs assessed by psychiatric health care and social services in a defined cohort of clients with mental disabilities.
European archives of psychiatry and clinical neuroscience 2005;255(1):57-64.
2005: Lennart Jansson; Erik Wennström; Frits-Axel Wiesel
The Need of Support and Service Questionnaire (NSSQ): a brief scale to assess needs in clients with long-term mental disabilities.
Nordic journal of psychiatry 2005;59(6):465-72.
2004: Erik Wennström; Dag Sörbom; Frits-Axel Wiesel
Factor structure in the Camberwell Assessment of Need.
The British journal of psychiatry : the journal of mental science 2004;185():505-10.
2003: Lennart Jansson; Karin Sonnander; Frits-Axel Wiesel
Clients with long-term mental disabilities in a Swedish county--conditions of life, needs of support and unmet needs of service provided by the public health and social service sectors.
European psychiatry : the journal of the Association of European Psychiatrists 2003;18(6):296-305.
2003: Erik G Jönsson; Rami Abou Jamra; Johannes Schumacher; Lena Flyckt; Gunnar Edman; Kaj Forslund; Marja Mattila-Evenden; Gunnar Rylander; Marie Asberg; Lars Bjerkenstedt; Frits-Axel Wiesel; Peter Propping; Sven Cichon; Markus M Nöthen; Göran C Sedvall
No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia.
Psychiatric genetics 2003;13(3):175-8.
2003: Erik G Jönsson; Lena Flyckt; Edgar Burgert; Marc-Antoine Crocq; Kaj Forslund; Marja Mattila-Evenden; Gunnar Rylander; Marie Asberg; Vishwajit L Nimgaonkar; Gunnar Edman; Lars Bjerkenstedt; Frits-Axel Wiesel; Göran C Sedvall
Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.
Psychiatric genetics 2003;13(1):1-12.
2003: Erik G Jönsson; Edgar Burgert; Marc-Antoine Crocq; J Petter Gustavsson; Kaj Forslund; Marja Mattila-Evenden; Gunnar Rylander; Lena Flyckt; Lars Bjerkenstedt; Frits-Axel Wiesel; Marie Asberg; Hans Bergman
Association study between dopamine D3 receptor gene variant and personality traits.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;117B(1):61-5.
2001: Lena Flyckt; Nikolaos Venizelos; Gunnar Edman; Lars Bjerkenstedt; Lars Hagenfeldt; Frits-Axel Wiesel
Aberrant tyrosine transport across the cell membrane in patients with schizophrenia.
Archives of general psychiatry 2001;58(10):953-8.
2001: Ola Gefvert; T Lundberg; IM Wieselgren; Mats Bergström; Bengt Långström; Frits-Axel Wiesel; Leif H Lindström
D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(2):105-10.
2000: Lena Flyckt; Frits-Axel Wiesel; J Borg; Gunnar Edman; Tor Ansved; O Sydow; Kristian Borg
Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives.
Journal of psychiatric research 2000;34(4-5):355-64.
2000: Lena Flyckt; Jörgen Borg; K Borg; Tor Ansved; Gunnar Edman; Lars Bjerkenstedt; Frits-Axel Wiesel
Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia.
Biological psychiatry 2000;47(11):991-9.
1999: J Yu; Lillemor Källström; Frits-Axel Wiesel; Allan E Johnson
Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Synapse (New York, N.Y.) 1999;34(3):192-207.
1999: Frits-Axel Wiesel; Jesper L R Andersson; G Westerberg; IM Wieselgren; Lars Bjerkenstedt; Lars Hagenfeldt; Bengt Långström
Tyrosine transport is regulated differently in patients with schizophrenia.
Schizophrenia research 1999;40(1):37-42.
1999: Lena Flyckt; O Sydow; Lars Bjerkenstedt; Gunnar Edman; E Rydin; Frits-Axel Wiesel
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls.
Psychiatry research 1999;86(2):113-29.
1998: J Yu; Héctor Coirini; Lillemor Källström; Frits-Axel Wiesel; Allan E Johnson
Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Synapse (New York, N.Y.) 1998;30(1):38-48.
1998: Gisela E Hagberg; Ola Gefvert; Mats Bergström; IM Wieselgren; Leif H Lindström; Frits-Axel Wiesel; Bengt Långström
N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.
Psychiatry research 1998;82(3):147-60.
1997: Héctor Coirini; Lillemor Källström; Frits-Axel Wiesel; Allan E Johnson
Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptors.
Brain research. Molecular brain research 1997;49(1-2):197-210.
1996: Erik G Jönsson; Göran C Sedvall; Stefan Brené; J Petter Gustavsson; Thomas Geijer; Lars Terenius; Marc-Antoine Crocq; Lars Lannfelt; A Tylec; Pierre Sokoloff; J C Schwartz; Frits-Axel Wiesel
Dopamine-related genes and their relationships to monoamine metabolites in CSF.
Biological psychiatry 1996;40(10):1032-43.
1996: Frits-Axel Wiesel; Lars Bjerkenstedt
Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia.
Prostaglandins, leukotrienes, and essential fatty acids 1996;55(1-2):55-8.
1995: Per Karlsson; L Smith; Lars Farde; C Härnryd; Göran C Sedvall; Frits-Axel Wiesel
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients.
Psychopharmacology 1995;121(3):309-16.
1995: Allan E Johnson; Héctor Coirini; Lillemor Källström; L M Gunne; Frits-Axel Wiesel
Neuroleptics differentially modulate central dopamine D1-receptor binding.
Neuroreport 1995;6(6):933-6.
1994: Allan E Johnson; U Liminga; A Lidén; N Lindefors; L M Gunne; Frits-Axel Wiesel
Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain.
Neuroscience 1994;63(4):1003-20.
1994: Robert Freedman; Ingrid Strömberg; Anna-Lena Nordström; A Seiger; Lars Olson; M Bygdeman; Frits-Axel Wiesel; Ann-Charlotte E. Granholm-Bentley; Barry Hoffer
Neuronal development in embryonic brain tissue derived from schizophrenic women and grafted to animal hosts.
Schizophrenia research 1994;13(3):259-70.
1994: Frits-Axel Wiesel; Nikolaos Venizelos; Lars Bjerkenstedt; L Hagenfeldt
Tyrosine transport in schizophrenia.
Schizophrenia research 1994;13(3):255-8.
1994: Allan E Johnson; Héctor Coirini; Lillemor Källström; Frits-Axel Wiesel
Characterization of dopamine receptor binding sites in the subthalamic nucleus.
Neuroreport 1994;5(14):1836-8.
1994: Frits-Axel Wiesel
Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
The British journal of psychiatry. Supplement 1994;(23):65-70.
1994: Frits-Axel Wiesel; Anna-Lena Nordström; Lars Farde; B Eriksson
An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.
Psychopharmacology 1994;114(1):31-8.
1993: Anna-Lena Nordström; Lars Farde; Frits-Axel Wiesel; K Forslund; Stefan Pauli; Christer Halldin; G Uppfeldt
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
Biological psychiatry 1993;33(4):227-35.
1993: Frits-Axel Wiesel
Neuroleptics and diagnostic heterogeneity in relation to drug evaluation.
Psychopharmacology series 1993;10():124-30.
1992: R Freedman; Ingrid Strömberg; A Seiger; Lars Olson; Anna-Lena Nordström; Frits-Axel Wiesel; M Bygdeman; C Wetmore; M R Palmer; Barry Hoffer
Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women.
Biological psychiatry 1992;32(12):1148-63.
1992: Lars Farde; Anna-Lena Nordström; Frits-Axel Wiesel; Stefan Pauli; Christer Halldin; Göran C Sedvall
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.
Archives of general psychiatry 1992;49(7):538-44.
1992: Frits-Axel Wiesel
Metabolic approaches to physiologic subtyping of schizophrenia.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():26A-27A.
1992: Frits-Axel Wiesel
Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment.
Progress in neuro-psychopharmacology & biological psychiatry 1992;16(6):871-81.
1992: Lars Farde; Anna-Lena Nordström; Christer Halldin; Frits-Axel Wiesel; Göran C Sedvall
PET studies of dopamine receptors in relation to antipsychotic drug treatment.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():468A-469A.
1992: Frits-Axel Wiesel
The significance of the D2 dopamine receptor in schizophrenia as studied with PET.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():460A-461A.
1991: Frits-Axel Wiesel; G Blomqvist; Christer Halldin; I Sjögren; Lars Bjerkenstedt; Nikolaos Venizelos; L Hagenfeldt
The transport of tyrosine into the human brain as determined with L-[1-11C]tyrosine and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(11):2043-9.
1991: Gustav Wik; Frits-Axel Wiesel
Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia.
Psychiatry research 1991;40(2):101-14.
1991: C von Bahr; Frits-Axel Wiesel; G Movin; P Eneroth; P Jansson; L Nilsson; S Ogenstad
Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers.
Psychopharmacology 1991;103(4):443-8.
1990: G Blomqvist; Sharon Stone-Elander; Christer Halldin; Per E Roland; L Widén; M Lindqvist; C G Swahn; B Långström; Frits-Axel Wiesel
Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1990;10(4):467-83.
1990: Lars Farde; Frits-Axel Wiesel; Sharon Stone-Elander; Christer Halldin; Anna-Lena Nordström; Håkan Hall; Göran C Sedvall
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Archives of general psychiatry 1990;47(3):213-9.
1990: G Alfredsson; Frits-Axel Wiesel
Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.
Psychopharmacology 1990;101(3):324-31.
1990: Frits-Axel Wiesel; Lars Farde; Anna-Lena Nordström; Göran C Sedvall
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(5):759-67.
1990: Göran C Sedvall; Lars Farde; H Nybäck; Stefan Pauli; A Persson; I Savic; Frits-Axel Wiesel
Recent advances in psychiatric brain imaging.
Acta radiologica. Supplementum 1990;374():113-5.
1989: Lars Farde; Frits-Axel Wiesel; L Nilsson; Göran C Sedvall
The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics.
Psychopharmacology series 1989;7():32-9.
1989: Frits-Axel Wiesel; G Alfredsson; E Jönsson
Dose finding and serum concentrations of neuroleptics in the treatment of schizophrenic patients.
Psychopharmacology series 1989;7():303-10.
1989: Frits-Axel Wiesel; Lars Farde; Christer Halldin
Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
Acta psychiatrica Scandinavica. Supplementum 1989;352():30-4.
1989: Lars Farde; Frits-Axel Wiesel; Anna-Lena Nordström; Göran C Sedvall
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.
Psychopharmacology 1989;99 Suppl():S28-31.
1989: Frits-Axel Wiesel
Positron emission tomography in psychiatry.
Psychiatric developments 1989;7(1):19-47.
1989: Gustav Wik; Frits-Axel Wiesel; I Sjögren; G Blomqvist; T Greitz; Sharon Stone-Elander
Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.
Psychopharmacology 1989;97(3):309-18.
1989: G Alfredsson; Frits-Axel Wiesel
Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.
Psychopharmacology 1989;99(3):322-7.
1988: Gustav Wik; S Borg; I Sjögren; Frits-Axel Wiesel; G Blomqvist; J Borg; T Greitz; H Nybäck; Göran C Sedvall; Sharon Stone-Elander
PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose.
Acta psychiatrica Scandinavica 1988;78(2):234-41.
1988: G Alfredsson; Frits-Axel Wiesel; A Tylec
Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
Biological psychiatry 1988;23(7):689-97.
1988: G Alfredsson; Frits-Axel Wiesel; M Lindberg
Glutamate and glutamine in cerebrospinal fluid and serum from healthy volunteers--analytical aspects.
Journal of chromatography 1988;424(2):378-84.
1988: Lars Farde; Frits-Axel Wiesel; P Jansson; G Uppfeldt; A Wahlen; Göran C Sedvall
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET.
Psychopharmacology 1988;94(1):1-7.
1988: Göran C Sedvall; Lars Farde; Håkan Hall; Stefan Pauli; A Persson; Frits-Axel Wiesel
PET scanning--a new tool in clinical psychopharmacology.
Psychopharmacology series 1988;5():27-33.
1988: Lars Farde; Frits-Axel Wiesel; Christer Halldin; Göran C Sedvall
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
Archives of general psychiatry 1988;45(1):71-6.
1987: Frits-Axel Wiesel; Gustav Wik; I Sjögren; G Blomqvist; T Greitz; Sharon Stone-Elander
Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.
Acta psychiatrica Scandinavica 1987;76(6):628-41.
1987: Frits-Axel Wiesel; Gustav Wik; I Sjögren; G Blomqvist; T Greitz
Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients.
Acta psychiatrica Scandinavica 1987;76(6):642-7.
1987: A Amdisen; M S Nielsen; S J Dencker; C Fensbo; U G Ahlfors; A Gravem; P C Baastrup; Lars Bjerkenstedt; B Gunby; Frits-Axel Wiesel
Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses.
Acta psychiatrica Scandinavica 1987;75(1):99-107.
1986: Håkan Nyman; H Nybäck; Frits-Axel Wiesel; G Oxenstierna; D Schalling
Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients.
Acta psychiatrica Scandinavica 1986;74(3):292-301.
1986: Gustav Wik; Frits-Axel Wiesel; P Eneroth; Göran C Sedvall; G Aström
Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment.
Acta psychiatrica Scandinavica 1986;74(2):161-7.
1986: C Bohm; T Greitz; G Blomqvist; Lars Farde; P O Forsgren; D Kingsley; I Sjögren; Frits-Axel Wiesel; Gustav Wik
Applications of a computerized adjustable brain atlas in positron emission tomography.
Acta radiologica. Supplementum 1986;369():449-52.
1985: Lars Bjerkenstedt; Gunnar Edman; L Hagenfeldt; Göran C Sedvall; Frits-Axel Wiesel
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls.
The British journal of psychiatry : the journal of mental science 1985;147():276-82.
1985: Lars Bjerkenstedt; Gunnar Edman; L Flyckt; L Hagenfeldt; Göran C Sedvall; Frits-Axel Wiesel
Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients.
Psychopharmacology 1985;87(3):253-9.
1985: G Alfredsson; C Härnryd; Frits-Axel Wiesel
Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
Psychopharmacology 1985;85(1):8-13.
1984: L Hagenfeldt; Lars Bjerkenstedt; Gunnar Edman; Göran C Sedvall; Frits-Axel Wiesel
Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
Journal of neurochemistry 1984;42(3):833-7.
1984: G Alfredsson; C Härnryd; Frits-Axel Wiesel
Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
Psychopharmacology 1984;84(2):237-41.
1984: C Härnryd; Lars Bjerkenstedt; K Björk; B Gullberg; G Oxenstierna; Göran C Sedvall; Frits-Axel Wiesel; Gustav Wik; A Aberg-Wistedt
Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine.
Acta psychiatrica Scandinavica. Supplementum 1984;311():7-30.
1984: Göran C Sedvall; L Iselius; H Nybäck; L Oreland; G Oxenstierna; S B Ross; Frits-Axel Wiesel
Genetic studies of CSF monoamine metabolites.
Advances in biochemical psychopharmacology 1984;39():79-85.
1984: C Härnryd; Lars Bjerkenstedt; B Gullberg; G Oxenstierna; Göran C Sedvall; Frits-Axel Wiesel
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients.
Acta psychiatrica Scandinavica. Supplementum 1984;311():75-92.
1984: G Alfredsson; Lars Bjerkenstedt; Gunnar Edman; C Härnryd; G Oxenstierna; Göran C Sedvall; Frits-Axel Wiesel
Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
Acta psychiatrica Scandinavica. Supplementum 1984;311():49-74.
1983: H Nybäck; B M Berggren; T Hindmarsh; Göran C Sedvall; Frits-Axel Wiesel
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers.
Psychiatry research 1983;9(4):301-8.
1982: Frits-Axel Wiesel; B Fyrö; H Nybäck; Göran C Sedvall; B Wode-Helgodt
Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity.
Biological psychiatry 1982;17(12):1403-13.
1982: H Nybäck; Frits-Axel Wiesel; B M Berggren; T Hindmarsh
Computed tomography of the brain in patients with acute psychosis and in healthy volunteers.
Acta psychiatrica Scandinavica 1982;65(6):403-14.
1982: Frits-Axel Wiesel; G Alfredsson; M Ehrnebo; Göran C Sedvall
Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations.
Psychopharmacology 1982;76(1):44-7.
1980: Frits-Axel Wiesel; G Alfredsson; M Ehrnebo; Göran C Sedvall
The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
European journal of clinical pharmacology 1980;17(5):385-91.
1980: Göran C Sedvall; B Fyrö; B Gullberg; H Nybäck; Frits-Axel Wiesel; B Wode-Helgodt
Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
The British journal of psychiatry : the journal of mental science 1980;136():366-74.
1976: Frits-Axel Wiesel
Effects of high dose propranolol treatment on dopamine and norepinephrine metabolism in regions of rat brain.
Neuroscience letters 1976;2(1):35-8.